Clinical Trial Update: Efficacy and Safety of Everolimus in Liver Transplant Recipients of Living Donor Liver Transplants [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating efficacy and safety of everolimus in living donor liver transplant recipients completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Transplantation

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Liver Transplantation | Phase 3 | Status: COMPLETED | Results posted: 2018-11-13